FluBlok, a next generation influenza vaccine manufactured in insect cells
FluBlok, a recombinant trivalent hemagglutinin (rHA) vaccine produced in insect cell culture using the baculovirus expression system, provides an attractive alternative to the current egg-based trivalent inactivated influenza vaccine (TIV). Its manufacturing process presents the possibility for safe...
Saved in:
Published in | Biologicals Vol. 37; no. 3; pp. 182 - 189 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.06.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!